Stocks to Watch: HDFC Bank, Vodafone Idea, Bharat Biotech, Cadila, Muthoot Finance

HDFC Bank announced almost 20% ascent in independent net benefit at ₹6,658.62 crores for June quarter
Vodafone Idea has paid an extra ₹1,000 crore to the legislature as a component of its duty identified with balanced gross income
Here’s a rundown of top stocks that might be in news on Monday:
HDFC Bank: Shareholders of HDFC Bank have offered endorsement to raise up to ₹50,000 crores through securities to improve capital base to subsidize its business development. The bank on Saturday announced almost 20% ascent in independent net benefit at ₹6,658.62 crores for June quarter, 2020-21 on the rear of solid premium salary driven by development in progress.
Truly Bank: The private area loan specialist’s follow-on open offer (FPO) to raise ₹15,000 crores has figured out how to cruise through in the wake of getting bought in 93% on the last day of offering on Friday. The FPO membership would be 95% in the wake of including the grapple speculators’ part. Truly Bank would raise the focus on RS 15,000 crore with assistance from SBI Capital Markets, which had guaranteed the issue.
Vodafone Idea: Telecom administrator Vodafone Idea on Saturday said it has paid an extra ₹1,000 crore to the legislature as a feature of its levy identified with balanced gross income (AGR), taking its absolute installment to a total ₹7,854 crore.
Bharat Biotech: The pharma organization has gotten endorsement to direct stage I and II clinical preliminaries for its antibody applicant Covaxin, which has been created and produced in the organization’s office in Hyderabad. It a week ago began human clinical preliminaries.
Glenmark Pharmaceuticals: India’s medication controller has looked for an explanation from Glenmark Pharmaceuticals over its affirmed “bogus cases” about the utilization of hostile to viral FabiFlu on COVID-19 patients with comorbidities and furthermore over the “estimating” of the medication, in the wake of getting a grumbling from an individual from Parliament.
Cadila: The pharma organization has gotten the last endorsement from the US wellbeing controller to showcase conventional Butalbital, Acetaminophen, and Caffeine mix tablets to treat manifestations of strain migraines.
Muthoot Finance: The non-banking account organization on Saturday said its board has placed in cessation the proposition for a stock split considering the current financial circumstance brought about by COVID-19. “The board talked about inside and out the upsides and downsides of the stock split proposition. However, the offer value development in the course of the most recent couple of months and monetary pointers were seen as perfect for a stock split proposition at the current situation, the board collectively chose to concede the proposition to sub-partition the value offers to the organization to a future date,” Muthoot Finance said in a recording.
M&M Financial Services: The organization has detailed more than a two-crease bounce in an independent net benefit to ₹156 crores in the quarter finishing June helped by cost defense measures and lower subsidizing cost. It had revealed a benefit after the expense of ₹68 crores in a similar quarter of a year ago.
HUL: FMCG major HUL on Sunday said it has briefly shut down its Haridwar plant, where a few of its workers had been tried positive for COVID-19. “We can affirm that few workers at our Haridwar production line have been determined to have Covid-19 – a vast greater part of them being asymptomatic. This came out of a worker Covid-19 testing program we have actuated,” HUL said in an announcement.
Canara Bank: State-run Canara Bank will raise up to ₹5,000 crore value capital through different modes in the current financial year to help its capital sufficiency proportion taking into account extension designs, and will look for a gesture from investors for the equivalent in its AGM one month from now.